Staar Surgical (STAA) Receivables (2010 - 2026)

Staar Surgical's Receivables history runs 17 years deep, the most recent figure standing at $81.2 million for Q2 2026.

• Quarterly Receivables rose 103.19% year-over-year to $81.2 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $81.2 million (up 103.19% YoY) and the FY2026 annual result came in at $50.4 million, down 52.23% from the prior year.
• Receivables was $81.2 million for Q2 2026 at Staar Surgical, up from $50.4 million in the prior quarter.
• Across five years, Receivables topped out at $112.4 million in Q3 2023 and bottomed at $34.4 million in Q2 2025.
• A 5-year average of $72.2 million and a median of $63.5 million in 2023 frame the typical range for Receivables.
• Annual changes were most pronounced in 2025 — Receivables plunged 63.28% — and 2026, when it jumped 103.19%.
• Staar Surgical's Receivables stood at $62.5 million in 2022, then soared by 51.95% to $94.9 million in 2023, then increased by 11.07% to $105.4 million in 2024, then plunged by 42.97% to $60.1 million in 2025, then jumped by 35.05% to $81.2 million in 2026.
• Business Quant data shows STAA's Receivables at $81.2 million in Q2 2026, $50.4 million in Q1 2026, and $60.1 million in Q3 2025.